Oral submucous fibrosis in India: Are we progressing??

被引:7
作者
Hebbar, P. B. [1 ,2 ]
Sheshaprasad, R. [3 ]
Gurudath, S. [4 ]
Pai, A. [3 ]
Sujatha, D. [3 ]
机构
[1] Yashas Dent Hlth Care Ctr, Dept Oral Med, Bangalore, Karnataka, India
[2] Yashas Dent Hlth Care Ctr, Dept Radiol, Bangalore, Karnataka, India
[3] Oxford Dent Coll & Hosp, Bangalore, Karnataka, India
[4] KLE Inst Dent Sci, Bangalore, Karnataka, India
关键词
Aloe vera; lycopene; oral submucous fibrosis; oxitard; DRUG-TREATMENT; BETEL QUID; TREATMENT ADJUNCT; TURMERIC OIL; RISK-FACTORS; ONCOL; 2012; ARECA NUT; MANAGEMENT; PATHOGENESIS; EFFICACY;
D O I
10.4103/0019-509X.146724
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral submucous fibrosis (OSMF) a condition first described in the 1950s in the modern literature still remains elusive of a cure. For many years this condition had been confined to countries like India, Pakistan, Bangladesh, etc., but now this condition is being reported from Western countries as well. Inspite of intensive research over the years into the etiologic factors of OSMF, a single etiologic factor cannot be pointed out with certainty rather several causative factors have been proposed. Patients suffering with OSMF initially present with a blanched or marble-like pale mucosa, vesiculations, and also intolerance to hot and spicy food. Gradually, the patient may develop fibrous bands in the buccal and labial mucosa which causes a restriction in opening the mouth. The evidence for the various treatment modalities for OSMF is weak hence better documentation of the studies performed with standardized criteria is required. The current review aims to refresh our knowledge regarding OSMF from an Indian perspective and make a few suggestions to fill the lacunae in this field.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 49 条
[1]   EFFICACY OF AN ANTITOBACCO COMMUNITY EDUCATION-PROGRAM IN INDIA [J].
ANANTHA, N ;
NANDAKUMAR, A ;
VISHWANATH, N ;
VENKATESH, T ;
PALLAD, YG ;
MANJUNATH, P ;
KUMAR, DR ;
MURTHY, SGS ;
SHIVASHANKARIAH ;
DAYANANDA, CS .
CANCER CAUSES & CONTROL, 1995, 6 (02) :119-129
[2]   Little evidence that current interventions can benefit patients with OSMFQuestion: Do current interventions benefit patients with oral submucous fibrosis? [J].
Punnya V Angadi .
Evidence-Based Dentistry, 2011, 12 (2) :43-43
[3]   Areca nut in pathogenesis of oral submucous fibrosis: Revisited [J].
Angadi P.V. ;
Rao S.S. .
Oral and Maxillofacial Surgery, 2011, 15 (1) :1-9
[4]  
[Anonymous], 2012, TIMES INDIA, P12
[5]   Extended nasolabial flaps in the management of oral submucous fibrosis [J].
Borle, R. M. ;
Nimonkar, P. V. ;
Rajan, R. .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2009, 47 (05) :382-385
[6]  
Chaturvedi P., 2009, Indian Journal of Cancer, V46, P170, DOI 10.4103/0019-509X.49158
[7]  
Chiba Itsuo, 2001, Asian Pac J Cancer Prev, V2, P263
[8]   Review of drug treatment of oral submucous fibrosis [J].
Chole, Revant H. ;
Gondivkar, Shailesh M. ;
Gadbail, Amol R. ;
Balsaraf, Swati ;
Chaudhary, Sudesh ;
Dhore, Snehal V. ;
Ghonmode, Sumeet ;
Balwani, Satish ;
Mankar, Mugdha ;
Tiwari, Manish ;
Parikh, Rima V. .
ORAL ONCOLOGY, 2012, 48 (05) :393-398
[9]   Physiotherapeutic treatment improves oral opening in oral submucous fibrosis [J].
Cox, Stephen ;
Zoellner, Hans .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (02) :220-226
[10]   Habitual risk factors for head and neck cancer [J].
Goldenberg, D ;
Lee, J ;
Koch, WM ;
Kim, MM ;
Trink, B ;
Sidransky, D ;
Moon, CS .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 131 (06) :986-993